Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2.

Carmona-Rivera C, Zhao W, Yalavarthi S, Kaplan MJ.

Ann Rheum Dis. 2015 Jul;74(7):1417-24. doi: 10.1136/annrheumdis-2013-204837. Epub 2014 Feb 25.

2.

Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.

Chauhan SK, Rai R, Singh VV, Rai M, Rai G.

Immunol Lett. 2015 Dec;168(2):254-9. doi: 10.1016/j.imlet.2015.09.016. Epub 2015 Oct 3.

PMID:
26434792
3.

A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs.

Denny MF, Yalavarthi S, Zhao W, Thacker SG, Anderson M, Sandy AR, McCune WJ, Kaplan MJ.

J Immunol. 2010 Mar 15;184(6):3284-97. doi: 10.4049/jimmunol.0902199. Epub 2010 Feb 17. Erratum in: J Immunol. 2010 Sep 15;185(6):3779.

4.

Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice.

Knight JS, Subramanian V, O'Dell AA, Yalavarthi S, Zhao W, Smith CK, Hodgin JB, Thompson PR, Kaplan MJ.

Ann Rheum Dis. 2015 Dec;74(12):2199-206. doi: 10.1136/annrheumdis-2014-205365. Epub 2014 Aug 7.

5.

Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.

Wang H, Li T, Chen S, Gu Y, Ye S.

Arthritis Rheumatol. 2015 Dec;67(12):3190-200. doi: 10.1002/art.39296.

6.

Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus.

Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, Rubin CJ, Zhao W, Olsen SH, Klinker M, Shealy D, Denny MF, Plumas J, Chaperot L, Kretzler M, Bruce AT, Kaplan MJ.

J Immunol. 2011 Jul 1;187(1):538-52. doi: 10.4049/jimmunol.1100450. Epub 2011 May 25.

7.

Brief Report: Vitamin D Deficiency Is Associated With Endothelial Dysfunction and Increases Type I Interferon Gene Expression in a Murine Model of Systemic Lupus Erythematosus.

Reynolds JA, Rosenberg AZ, Smith CK, Sergeant JC, Rice GI, Briggs TA, Bruce IN, Kaplan MJ.

Arthritis Rheumatol. 2016 Dec;68(12):2929-2935. doi: 10.1002/art.39803.

PMID:
27390112
8.
9.

Ligation of signal inhibitory receptor on leukocytes-1 suppresses the release of neutrophil extracellular traps in systemic lupus erythematosus.

Van Avondt K, Fritsch-Stork R, Derksen RH, Meyaard L.

PLoS One. 2013 Oct 18;8(10):e78459. doi: 10.1371/journal.pone.0078459. eCollection 2013.

10.

Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus.

Knight JS, Zhao W, Luo W, Subramanian V, O'Dell AA, Yalavarthi S, Hodgin JB, Eitzman DT, Thompson PR, Kaplan MJ.

J Clin Invest. 2013 Jul;123(7):2981-93. doi: 10.1172/JCI67390. Epub 2013 Jun 3.

11.

Neutrophil Extracellular Traps Drive Endothelial-to-Mesenchymal Transition.

Pieterse E, Rother N, Garsen M, Hofstra JM, Satchell SC, Hoffmann M, Loeven MA, Knaapen HK, van der Heijden OWH, Berden JHM, Hilbrands LB, van der Vlag J.

Arterioscler Thromb Vasc Biol. 2017 Jul;37(7):1371-1379. doi: 10.1161/ATVBAHA.117.309002. Epub 2017 May 11.

PMID:
28495931
12.

The role of neutrophils in the pathogenesis of systemic lupus erythematosus.

Smith CK, Kaplan MJ.

Curr Opin Rheumatol. 2015 Sep;27(5):448-53. doi: 10.1097/BOR.0000000000000197. Review.

PMID:
26125102
13.

Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis.

Thacker SG, Zhao W, Smith CK, Luo W, Wang H, Vivekanandan-Giri A, Rabquer BJ, Koch AE, Pennathur S, Davidson A, Eitzman DT, Kaplan MJ.

Arthritis Rheum. 2012 Sep;64(9):2975-85. doi: 10.1002/art.34504.

14.

At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases.

Barnado A, Crofford LJ, Oates JC.

J Leukoc Biol. 2016 Feb;99(2):265-78. doi: 10.1189/jlb.5BT0615-234R. Epub 2015 Dec 11. Review.

15.

Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress.

Uemura S, Matsushita H, Li W, Glassford AJ, Asagami T, Lee KH, Harrison DG, Tsao PS.

Circ Res. 2001 Jun 22;88(12):1291-8.

16.
17.

Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus.

Faber-Elmann A, Sthoeger Z, Tcherniack A, Dayan M, Mozes E.

Clin Exp Immunol. 2002 Feb;127(2):393-8.

18.

The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves cardiometabolic risk and renal inflammation in murine lupus.

Zhao W, Thacker SG, Hodgin JB, Zhang H, Wang JH, Park JL, Randolph A, Somers EC, Pennathur S, Kretzler M, Brosius FC 3rd, Kaplan MJ.

J Immunol. 2009 Aug 15;183(4):2729-40. doi: 10.4049/jimmunol.0804341. Epub 2009 Jul 20.

19.

Tetrahydroisoquinolines: New Inhibitors of Neutrophil Extracellular Trap (NET) Formation.

Martinez NE, Zimmermann TJ, Goosmann C, Alexander T, Hedberg C, Ziegler S, Zychlinsky A, Waldmann H.

Chembiochem. 2017 May 18;18(10):888-893. doi: 10.1002/cbic.201600650. Epub 2017 Mar 31.

PMID:
28240414
20.

The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?

Narshi CB, Giles IP, Rahman A.

Lupus. 2011 Jan;20(1):5-13. doi: 10.1177/0961203310382429. Epub 2010 Dec 7. Review.

PMID:
21138982

Supplemental Content

Support Center